Press release
RNA Based Therapeutic Market 2023 Trends: Expected to Grow at a CAGR of 17.6% by 2030
Key Takeaways:
Rapid Growth: The RNA-based therapeutic market has experienced significant growth in recent years. This can be attributed to advancements in RNA technologies, increased understanding of disease mechanisms, and successful clinical trials of RNA-based drugs.
mRNA Vaccines: The COVID-19 pandemic has propelled the development and adoption of mRNA vaccines, such as the Pfizer-BioNTech and Moderna vaccines. These vaccines have demonstrated high efficacy in preventing COVID-19 and have brought mRNA therapeutics into the spotlight.
Gene Silencing: RNA-based therapeutics are being used for gene silencing to treat various diseases. Small interfering RNAs (siRNAs) and antisense oligonucleotides (ASOs) are designed to target specific RNA molecules and inhibit their expression, providing potential treatments for conditions like genetic disorders, cancers, and viral infections.
RNA Interference (RNAi): RNAi is a biological process that regulates gene expression by silencing target genes through the degradation of specific RNA molecules. This mechanism has been harnessed to develop RNA-based therapeutics that can selectively inhibit disease-causing genes, showing promise in treating genetic disorders and certain types of cancers.
Rare Diseases: RNA-based therapies have demonstrated significant potential in addressing rare diseases. These therapies can target specific genetic mutations responsible for rare disorders and offer personalized treatment options for patients with limited treatment choices.
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/546
Market Drivers:
Advancements in RNA Technologies: Rapid advancements in RNA technologies, such as mRNA synthesis, RNA interference (RNAi), and antisense oligonucleotides (ASOs), have expanded the possibilities for developing RNA-based therapeutics. These advancements have improved the stability, delivery, and specificity of RNA molecules, increasing their therapeutic potential.
Precision Medicine and Personalized Treatments: RNA-based therapeutics offer the potential for precise targeting of disease-causing genes or specific mutations. This personalized approach allows for tailored treatments based on an individual's genetic profile, leading to more effective and targeted therapies for various diseases, including rare genetic disorders.
Market Segmentation:
Therapeutic Modality:
a. mRNA Therapeutics: This segment includes mRNA-based therapies, such as mRNA vaccines, which encode specific proteins to elicit an immune response or deliver therapeutic molecules.
b. RNA Interference (RNAi): This segment encompasses RNAi-based therapeutics that utilize small interfering RNAs (siRNAs) or short hairpin RNAs (shRNAs) to silence or knockdown specific disease-causing genes.
c. Antisense Oligonucleotides (ASOs): ASOs are synthetic RNA molecules designed to bind to specific RNA targets and modulate gene expression, either by blocking translation or promoting degradation.
d. Others: This segment includes other RNA-based therapeutic modalities, such as aptamers or ribozymes, which have unique mechanisms of action.
Indication:
a. Infectious Diseases: This segment includes RNA-based therapeutics targeting viral or bacterial infections, such as mRNA vaccines for COVID-19 or RNA-based antiviral therapies.
b. Genetic Disorders: RNA-based therapeutics can target specific genetic mutations responsible for inherited diseases, including rare genetic disorders.
c. Cancer: RNA-based therapeutics are being developed to selectively target cancer cells or inhibit specific oncogenes, potentially offering personalized treatment options.
d. Neurological Disorders: This segment focuses on RNA-based therapies for neurological conditions like Alzheimer's disease, Parkinson's disease, or amyotrophic lateral sclerosis (ALS).
e. Cardiovascular Disorders: RNA-based therapeutics targeting cardiovascular diseases, such as atherosclerosis or heart failure, fall under this segment.
End User:
a. Hospitals and Clinics: RNA-based therapeutics may be administered in hospital or clinical settings, particularly for acute conditions or advanced therapies.
b. Research Institutes: Academic and research institutions play a crucial role in developing and studying RNA-based therapeutics.
c. Pharmaceutical and Biotechnology Companies: This segment includes companies involved in the research, development, and commercialization of RNA-based therapies.
Geography:
The market can also be segmented based on geographical regions, such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, as the adoption and regulatory landscape for RNA-based therapeutics may vary across different regions.
Request for Customization - https://www.alliedmarketresearch.com/request-for-customization/546
Competitive Landscape:
Silence Therapeutics plc.
Arbutus Biopharma Corporation
Ionis Pharmaceuticals
Sarepta Therapeutics
Alnylam Pharmaceuticals, Inc.
Benitec Biopharma Inc.
Genzyme (Sanofi), Arrowhead Pharmaceuticals
Biogen, Inc.
Gradalis, Inc.
Procure Complete Report at 20% Discount (258 Pages):
https://www.alliedmarketresearch.com/purchase-enquiry/546
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNA Based Therapeutic Market 2023 Trends: Expected to Grow at a CAGR of 17.6% by 2030 here
News-ID: 3121171 • Views: …
More Releases from Allied Market Research
Herbal Die tary Supplement Market Size, Industry Analysis, Growth Drivers, Oppor …
The herbal die tary supplement market size was valued at $11 billion in 2022, and is estimated to reach $21.4 billion by 2032, growing at a CAGR of 7.1% from 2023 to 2032.
Herbal die tary supplements are natural items made from plants or plant extracts that are taken to supplement the diet and improve health and well-being. These supplements frequently contain a combination of vitamins, minerals, amino acids, and other…
Mobile Application Security Market Growing at 26.3% CAGR Reach USD 37.1 Billion …
Allied Market Research published a new report, titled, "Mobile Application Security Market Growing at 26.3% CAGR Reach USD 37.1 Billion by 2032." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain a thorough understanding of the industry and determine…
MarTech Market Witnessing CAGR of 18.5% Hit USD 1.7 Trillion by 2032
The global marketing technology market is experiencing growth due to several factors, including the increasing digital transformation, the surge in demand for personalized experience, and the proliferation of automation and efficiency. However, data privacy and compliance, and the high cost of implementation are expected to hamper market growth. Furthermore, the growing integration of AI and ML technologies and the increase in demand for real-time marketing are anticipated to provide lucrative…
Feedback Management Software Market Growing with CAGR of 12.9% Reach USD 28.7 Bi …
Allied Market Research published a new report, titled, "Feedback Management Software Market Growing with CAGR of 12.9% Reach USD 28.7 Billion by 2031 ." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
